Literature DB >> 25015366

Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.

Helen Kim1, Rustam Al-Shahi Salman2, Charles E McCulloch2, Christian Stapf2, William L Young2.   

Abstract

OBJECTIVE: To identify risk factors for intracranial hemorrhage in the natural history course of brain arteriovenous malformations (AVMs) using individual patient data meta-analysis of 4 existing cohorts.
METHODS: We harmonized data from Kaiser Permanente of Northern California (n = 856), University of California San Francisco (n = 787), Columbia University (n = 672), and the Scottish Intracranial Vascular Malformation Study (n = 210). We censored patients at first treatment, death, last visit, or 10-year follow-up, and performed stratified Cox regression analysis of time-to-hemorrhage after evaluating hemorrhagic presentation, sex, age at diagnosis, deep venous drainage, and AVM size as predictors. Multiple imputation was performed to assess impact of missing data.
RESULTS: A total of 141 hemorrhage events occurred during 6,074 patient-years of follow-up (annual rate of 2.3%, 95% confidence interval [CI] 2.0%-2.7%), higher for ruptured (4.8%, 3.9%-5.9%) than unruptured (1.3%, 1.0%-1.7%) AVMs at presentation. Hemorrhagic presentation (hazard ratio 3.86, 95% CI 2.42-6.14) and increasing age (1.34 per decade, 1.17-1.53) independently predicted hemorrhage and remained significant predictors in the imputed dataset. Female sex (1.49, 95% CI 0.96-2.30) and exclusively deep venous drainage (1.60, 0.95-2.68, p = 0.02 in imputed dataset) may be additional predictors. AVM size was not associated with intracerebral hemorrhage in multivariable models (p > 0.5).
CONCLUSION: This large, individual patient data meta-analysis identified hemorrhagic presentation and increasing age as independent predictors of hemorrhage during follow-up. Additional AVM cohort data may further improve precision of estimates, identify new risk factors, and allow validation of prediction models.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25015366      PMCID: PMC4141996          DOI: 10.1212/WNL.0000000000000688

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials.

Authors:  R P Atkinson; I A Awad; H H Batjer; C F Dowd; A Furlan; S L Giannotta; C R Gomez; D Gress; G Hademenos; V Halbach; J C Hemphill; R T Higashida; L N Hopkins; M B Horowitz; S C Johnston; M W Lawton; M W McDermott; A M Malek; J P Mohr; A I Qureshi; H Riina; W S Smith; J Pile-Spellman; R F Spetzler; T A Tomsick; W L Young
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

2.  Annual risk for the first hemorrhage from untreated cerebral arteriovenous malformations.

Authors:  B Karlsson; C Lindquist; A Johansson; L Steiner
Journal:  Minim Invasive Neurosurg       Date:  1997-06

3.  Arteriovenous malformations and associated aneurysms.

Authors:  Kaith Almefty; Robert F Spetzler
Journal:  World Neurosurg       Date:  2011-11       Impact factor: 2.104

4.  Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients.

Authors:  Helen Kim; Stephen Sidney; Charles E McCulloch; K Y Trudy Poon; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Randall T Higashida; William L Young
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

5.  Meta-analysis of individual participant data: rationale, conduct, and reporting.

Authors:  Richard D Riley; Paul C Lambert; Ghada Abo-Zaid
Journal:  BMJ       Date:  2010-02-05

6.  Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS).

Authors:  Rustam Al-Shahi; Jo J Bhattacharya; David G Currie; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow
Journal:  Stroke       Date:  2003-04-17       Impact factor: 7.914

7.  Quantification of the completeness of follow-up.

Authors:  Taane G Clark; Douglas G Altman; Bianca L De Stavola
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

8.  Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations.

Authors:  Shigeki Yamada; Yasushi Takagi; Kazuhiko Nozaki; Ken-ichiro Kikuta; Nobuo Hashimoto
Journal:  J Neurosurg       Date:  2007-11       Impact factor: 5.115

9.  Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population.

Authors:  Alexander X Halim; S Claiborne Johnston; Vineeta Singh; Charles E McCulloch; John P Bennett; Achal S Achrol; Stephen Sidney; William L Young
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

10.  Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients.

Authors:  Juha A Hernesniemi; Reza Dashti; Seppo Juvela; Kristjan Väärt; Mika Niemelä; Aki Laakso
Journal:  Neurosurgery       Date:  2008-11       Impact factor: 4.654

View more
  44 in total

1.  Evaluation of Angioarchitectural Features of Unruptured Brain Arteriovenous Malformation by Susceptibility Weighted Imaging.

Authors:  Chun-Xue Wu; Li Ma; Xu-Zhu Chen; Xiao-Lin Chen; Yu Chen; Yuan-Li Zhao; Christopher Hess; Helen Kim; Heng-Wei Jin; Jun Ma
Journal:  World Neurosurg       Date:  2018-05-30       Impact factor: 2.104

2.  Management of brain arteriovenous malformations.

Authors:  Sherri A Braksick; Jennifer E Fugate
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

3.  Viewpoints on the ARUBA trial.

Authors:  J P Mohr; A Hartmann; H Kim; J Pile-Spellman; C Stapf
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-26       Impact factor: 3.825

4.  Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study.

Authors:  Cindy Tiseo; Antonio Carolei
Journal:  Intern Emerg Med       Date:  2018-11-07       Impact factor: 3.397

5.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.

Authors:  Santosh B Murthy; Alexander E Merkler; Setareh Salehi Omran; Gino Gialdini; Aaron Gusdon; Benjamin Hartley; David Roh; Halinder S Mangat; Costantino Iadecola; Babak B Navi; Hooman Kamel
Journal:  Neurology       Date:  2017-04-19       Impact factor: 9.910

6.  Microsurgical resection of brain arteriovenous malformations in the elderly: outcomes analysis and risk stratification.

Authors:  Jan-Karl Burkhardt; George F Lasker; Ethan A Winkler; Helen Kim; Michael T Lawton
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

7.  Long-term outcomes in pediatric unruptured brain arteriovenous malformation treated by nonconservative management: a single center analysis.

Authors:  Sukwoo Hong; Hideki Ogiwara
Journal:  Childs Nerv Syst       Date:  2019-06-15       Impact factor: 1.475

8.  Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.

Authors:  Helen Kim; Jeffrey Nelson; Timo Krings; Karel G terBrugge; Charles E McCulloch; Michael T Lawton; William L Young; Marie E Faughnan
Journal:  Stroke       Date:  2015-04-09       Impact factor: 7.914

9.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

Review 10.  Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment.

Authors:  Gabor A Fulop; Stefano Tarantini; Andriy Yabluchanskiy; Andrea Molnar; Calin I Prodan; Tamas Kiss; Tamas Csipo; Agnes Lipecz; Priya Balasubramanian; Eszter Farkas; Peter Toth; Farzaneh Sorond; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-08       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.